China Pharma And Distributors Suffer From Essential Drug System And Price Cuts

SHANGHAI - While many investors are looking forward to a rebound in the second half of 2011 following a disappointing first half, analysts from Morgan Stanley poured cold water on investor hopes in Hong Kong by downgrading pharma and distribution sectors in a July 7 research note